ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs 22 Sep 2023 The Institute of Cancer Research, London, and science and technology company Merck have renewed their strategic alliance in the discovery and development of new cancer drugs. Find out more Show/Hide
Meet our scientists at upcoming industry collaboration events 22 Feb 2023 Upcoming events will give industry experts the chance to hear from some of our leading researchers about opportunities to work with them. Find out more Show/Hide
Innovative ICR-discovered drug to enter first clinical trial, targeting HSF1 pathway 26 Aug 2021 Cancer patients are set to receive, for the first time, a highly innovative investigational drug called NXP800 – which was discovered at The Institute of Cancer Research, London. Find out more Show/Hide